GM-CSF allows higher doses of chemotherapy for sarcoma patients.
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D012509:Sarcoma / Q000628:therapy*
D016178:Granulocyte-Macrophage Colony-Stimulating Factor